-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SnWaE8VumHWFw44fuU1QgzFJ/+4HL723xBc+sA/rMO4sRYlBh3DHIQI6wSABV/8v r3MISa30dOoVwaTgESzpNA== 0001104659-06-072222.txt : 20061107 0001104659-06-072222.hdr.sgml : 20061107 20061107163621 ACCESSION NUMBER: 0001104659-06-072222 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20061107 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20061107 DATE AS OF CHANGE: 20061107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SRS LABS INC CENTRAL INDEX KEY: 0001016470 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 330714264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21123 FILM NUMBER: 061194325 BUSINESS ADDRESS: STREET 1: 2909 DAIMIER ST CITY: SANTA ANA STATE: CA ZIP: 92705 BUSINESS PHONE: 9494421070 MAIL ADDRESS: STREET 1: 2909 DAIMLER ST CITY: SANTA ANA STATE: CA ZIP: 92705 8-K 1 a06-23456_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 7, 2006

SRS LABS, INC.

(Exact Name of registrant as specified in its charter)

Delaware

 

0-21123

 

33-0714264

(State or other jurisdiction of

 

(Commission File Number)

 

(IRS Employer

incorporation)

 

 

 

Identification No.)

 

2909 Daimler Street

 

 

Santa Ana, California

 

92705

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (949) 442-1070

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 2.02.              Results of Operation and Financial Condition.

The information being furnished in this Item 2.02 and in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

On November 7, 2006, SRS Labs, Inc. issued a press release announcing its operating results for the three and nine months ended September 30, 2006.  A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01.              Financial Statements and Exhibits.

Exhibit No.

 

Description

99.1

 

Press Release dated November 7, 2006.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SRS LABS, INC.,

 

a Delaware corporation

 

 

 

 

 

 

Date: November 7, 2006

By:

 /S/ THOMAS C.K. YUEN

 

 

Thomas C.K. Yuen

 

 

Chairman of the Board and

 

 

Chief Executive Officer

 

2


 EX-99.1 2 a06-23456_1ex99d1.htm EX-99

Exhibit 99.1

FOR IMMEDIATE RELEASE

Investor Contact:

Ulrich Gottschling

Chief Financial Officer

(949) 442-5596

ir@srslabs.com

SRS LABS REPORTS RECORD THIRD QUARTER LICENSING REVENUES AND LICENSING NET INCOME

Santa Ana, Calif., November 7, 2006 - SRS Labs, Inc. (NASDAQ: SRSL), a leading supplier of surround sound, audio, and voice technologies, announced today that for the third quarter ended September 30, 2006, licensing revenue from continuing operations, increased by 34.9 percent to $4.9 million from $3.6 million for the same period in fiscal 2005, and net income from continuing operations increased to $1.3 million, or $.08  per diluted share, compared to $707 thousand, or $.05 per diluted share, for the same period in the prior year. Included in operating expenses from continuing operations for the three month period ended September 30, 2006 is $383 thousand related to stock based compensation expensing.

The Company also reported consolidated net income for the third quarter ended September 30, 2006 of $2.4 million or $.15 per diluted shared, compared to $704 thousand or $.05 per diluted share for the same period in the prior year.

For the nine months ended September 30, 2006, licensing revenue from continuing operations increased by 29.3 percent to $13.5 million from $10.4 million for the same period in fiscal 2005 and net income from continuing operations increased to $1.8 million, or $.11 per diluted share from $1.3 million, or $.09 per diluted share for the same period in fiscal 2005.  Consolidated net income for the nine months ended September 30, 2006 increased to $3.5 million or $.21 per diluted share compared to $1.4 million or $.10 per diluted share for the same period in the prior year.  Included in operating expenses from continuing operations for the nine month period ended September 30, 2006 is $1.2 million related to stock based compensation expensing.

Thomas C.K. Yuen, Chairman and CEO of SRS Labs, Inc., commenting on the quarter,

 “We are very pleased with the results of this current quarter in many different ways.

·                  From a revenue perspective, we made strong gains with unit volumes in flat panel TVs, car audio, and in the digital audio accessory market.

·                  From a net income perspective, due to our  highly “leverage-able” business model , one  in which increases in top line production , generally, does not require proportionate increases in costs nor operating  expenses,  we were able to realize greater improvement in net income.  We believe that we are positioned to continue to drive revenue growth while keeping increases in operating expenses low.

·                  From a marketing and branding perspective, we are seeing more products appearing on retail shelves and in advertisements by major consumer brands featuring our logo world wide, especially in the highly visible large flat panel TV market.  This quarter, we were very pleased to announce our new relationship with Sharper Image. Beginning this holiday season, a variety of consumer products prominently featuring our technologies and logo will appear in Sharper Image stores nationwide, as well as in their widely distributed catalogs. We appreciate this unique opportunity to enhance our visibility and collaborating with a highly regarded partner. Additionally, we launched two online downloadable audio enhancement software products, the iWOW for Apple based products and the SRS Audio Sandbox “SAS” for Microsoft Windows based products.  Through these offerings, which are available at http://www.srs-store.com/store-plugins/mall/sas-plugin.aspt, we hope to build more direct consumer awareness as well as exploring other revenue opportunities based on our technology and similar business models.



·                  Lastly, we are also pleased to have completed the sale of Valence Technology Limited to allow us to focus all of our attention on the audio technology licensing portion of our business. “

In February 2006, SRS announced its intention to sell its Hong Kong-based semiconductor business, Valence Technology Limited.  On July 14, 2006, the Company entered into a definitive Sale and Purchase Agreement (“Purchase Agreement”) and on September 29, 2006, the Company completed the transaction, which resulted in a gain on sale of $261 thousand.  For the period July 1, 2006 through the date of sale, Valence Technology Limited reported net income from operations of $857 thousand.  Both the gain on sale and the results from operations are included in discontinued operations.

Conference Call
SRS will host a conference call and webcast at 2 p.m. Pacific time today (5 p.m. Eastern Time) to review its fiscal 2006 third quarter results. The dial-in number for the call is (866) 814-8483, ask for “SRS Labs Q3 Results Conference Call” or provide conference call ID 982704.  An audio replay of the conference call will be available until November 14 at 6:00pm Pacific time via telephone.  The audio replay dial-in numbers is (866) 837-8032 and enter conference ID 982704.

The call will also be webcast live over the Internet.  Simply log-on to http://phx.corporate-ir.net/playerlink.zhtml?c=97327&s=wm&e=1401222.  The webcast will be archived on the company’s website for 60 days following the call.

About SRS Labs, Inc.
SRS Labs is a recognized leader in the advancement of audio and voice technology. The company works with the world’s top manufacturers to provide a richer entertainment experience through patented sound techniques. SRS Labs’ technologies can be heard through products ranging from televisions, LCD and plasma monitors, cell phones, MP3 players, car audio systems, and notebook and desktop computers. The company also offers hardware and software tools to professionals and consumers for the creation, production and broadcast of content featuring SRS Labs’ technologies. Based in Santa Ana, Calif., the company also has licensing representation in Hong Kong, Taiwan, Japan, China, Europe, and Korea. For more information about SRS Labs, Inc. please visit www.srslabs.com. The information on the aforementioned website is not incorporated by reference into this press release.

Except for historical information contained in this release, statements in this release, including those of Mr. Yuen are forward-looking statements and projections (which include statements concerning plans and objectives of management for future operations) that are based on management’s belief, as well as assumptions made by, and information currently available to management.  While the company believes that its expectations are based upon reasonable assumptions, there can be no assurances that the company’s goals and strategy will be realized. Numerous factors, including risks and uncertainties, may affect the company’s actual results and may cause results to differ materially from those expressed in forward-looking statements made by or on behalf of the company. Some of these factors include, the acceptance of new SRS Labs’ products and technologies, the impact of competitive products and pricing, the timely development and release of technologies by the company, general business and economic conditions, especially in Asia, and other factors detailed in the company’s Form 10-K and other periodic reports filed with the SEC.  SRS Labs specifically disclaims any obligation to update or revise any forward-looking statement whether as a result of new information, future developments or otherwise.

— More —

SRS Labs, Inc. 2909 Daimler Street, Santa Ana, CA  92705    Tel 949-442-1070    Fax 949-852-1099   www.srslabs.com



SRS LABS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

September 30,
2006

 

December 31,
2005

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash and cash equivalents

 

$

26,126,915

 

$

8,752,339

 

Accounts receivable, net

 

2,289,830

 

1,886,780

 

Inventories, net

 

158,253

 

80,421

 

Prepaid expenses and other current assets

 

910,902

 

522,426

 

Investments available for sale

 

1,993,279

 

—

 

Assets held for sale

 

—

 

1,859,127

 

 

 

 

 

 

 

Total Current Assets

 

31,479,179

 

13,101,093

 

 

 

 

 

 

 

Investments available for sale

 

5,211,295

 

17,077,170

 

Furniture, fixtures and equipment, net

 

441,453

 

425,288

 

Intangible assets, net

 

2,096,507

 

2,015,605

 

Deferred income taxes

 

386,412

 

380,386

 

Long term assets held for sale

 

—

 

2,065,123

 

 

 

 

 

 

 

Total Assets

 

$

39,614,846

 

$

35,064,665

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Accounts payable

 

$

898,289

 

$

741,811

 

Accrued liabilities

 

1,113,929

 

801,898

 

Deferred revenue

 

440,861

 

537,636

 

Liabilities related to assets held for sale

 

—

 

2,170,701

 

 

 

 

 

 

 

Total Current Liabilities

 

2,453,079

 

4,252,046

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

Preferred stock—$.001 par value; 2,000,000 shares authorized; no shares issued or outstanding

 

—

 

—

 

Common stock—$.001 par value; 56,000,000 shares authorized; 15,657,751 and 14,953,690 shares issued; and 14,983,653 and 14,279,592 shares outstanding at September 30, 2006 and December 31, 2005, respectively

 

15,659

 

14,955

 

Additional paid-in capital

 

66,239,460

 

63,574,518

 

Accumulated other comprehensive loss

 

(295,131

)

(496,021

)

Accumulated deficit

 

(25,794,776

)

(29,277,388

)

Treasury stock at cost, 674,098 shares at September 30, 2006 and December 31, 2005

 

(3,003,445

)

(3,003,445

)

 

 

 

 

 

 

Total Stockholders’ Equity

 

37,161,767

 

30,812,619

 

 

 

 

 

 

 

Total Liabilities and Stockholders’ Equity

 

$

39,614,846

 

$

35,064,665

 

 



SRS LABS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30,

 

September 30,

 

 

 

2006

 

2005

 

2006

 

2005

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

4,910,203

 

$

3,640,134

 

$

13,505,710

 

$

10,444,206

 

Cost of sales

 

43,998

 

39,804

 

127,103

 

190,987

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

4,866,205

 

3,600,330

 

13,378,607

 

10,253,219

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Sales and marketing

 

1,743,660

 

1,087,025

 

5,494,445

 

3,295,949

 

Research and development

 

628,227

 

584,008

 

1,914,255

 

1,708,000

 

General and administrative

 

1,277,601

 

1,198,433

 

4,272,598

 

3,898,785

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

3,649,488

 

2,869,466

 

11,681,298

 

8,902,734

 

 

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

1,216,717

 

730,864

 

1,697,309

 

1,350,485

 

Other income, net

 

291,236

 

176,707

 

694,954

 

486,318

 

Income from continuing operations before income tax expense

 

1,507,953

 

907,571

 

2,392,263

 

1,836,803

 

Income tax expense

 

231,620

 

200,420

 

558,788

 

487,950

 

Income from continuing operations

 

1,276,333

 

707,151

 

1,833,475

 

1,348,853

 

 

 

 

 

 

 

 

 

 

 

Discontinued operations:

 

 

 

 

 

 

 

 

 

Income (loss) from discontinued operations before income tax expense (benefit)

 

859,843

 

(123,490

)

1,054,095

 

(24,257

)

Gain on disposal

 

260,763

 

—

 

632,058

 

—

 

Income tax expense (benefit)

 

6,320

 

(120,533

)

37,016

 

(114,792

)

Income (loss) from discontinued operations

 

1,114,286

 

(2,957

)

1,649,137

 

90,535

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

2,390,619

 

$

704,194

 

$

3,482,612

 

$

1,439,388

 

 

 

 

 

 

 

 

 

 

 

Income from continuing operations per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.09

 

$

0.05

 

$

0.13

 

$

0.10

 

Diluted

 

$

0.08

 

$

0.05

 

$

0.11

 

$

0.09

 

 

 

 

 

 

 

 

 

 

 

Income from discontinued operations per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.07

 

$

0.00

 

$

0.11

 

$

0.01

 

Diluted

 

$

0.07

 

$

0.00

 

$

0.10

 

$

0.01

 

 

 

 

 

 

 

 

 

 

 

Net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.16

 

$

0.05

 

$

0.24

 

$

0.10

 

Diluted

 

$

0.15

 

$

0.05

 

$

0.21

 

$

0.10

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares used in the calculation of net income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

14,939,806

 

14,094,690

 

14,663,767

 

14,076,833

 

Diluted

 

16,479,112

 

15,300,803

 

16,428,894

 

15,070,362

 

 

 


 GRAPHIC 3 g234561bai001.jpg GRAPHIC begin 644 g234561bai001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#E_B+\0M=U M3Q#?Z;#>RVEA:SO"D,+%"^T[26(Y.2,XZD7ELRW)4F6WO M?GA![MCD8[@9-=QX]^&>A:OKLD]AKEKIVK71,KVMQ(-LA[D#JI)Y[]:\GU"S MUGP1KS6PO?L]Y#AA):3Y!!ZN?$MGX>U2\`^T/8L MDI`P&9967=CWQFK&E>'O']UX+%]I=W<'1]DC""*[V_*"=WR9]0>.]`&G\*_' M.MV_B5--O+VXO;*6*0M',Y1]W&.G-0+'; M^;LAB!.!GM]2:Z/X*7^EV_BX6EU8^9=W4;I!M+Q+\)- M/NM5O/\`A&-=L?,C<^9I\\P#1'KM!';GN/QH`C\*_"[QA9Z[;.FJBSL3\\EY M8W>X$#^$#N3[C%>E?$3QC_PA7AK[1"!+>SMY5L'Y&['+'U`'ZD5\]Z-XAUOP M=K!:QNWC>"4K+"LFZ*3!Y!`X(]_RKT_XX13WFC:!K*1,;96/F+_=+A6&?^^2 M*`.B\'>!_MME!KWB^235M4NE$JQW3%H[=3R`$Z9Q[<=!7._%?Q_<:#<#POX= M9;(QH&N)8`%*;N0BX^[QR2/6O5]*OK?4M)M+ZU<-!/"KH1Z$5\X_%NPN+'XB M:B\ZD)=;9HF/1E*@?H01^%`')_;KS[3]J^US^?G/F^8=^?KUKV'X4_$"XUNX M/A;Q$PO?-0FWEG`8OCDHV?O<#()]/I7B]=C\*+">^^(FFM"IVVS--*P_A4*? MYD@?C0!ZYXO\!I;V<^M>$6?2-6ME,FVT.R.X`Y*E!QGTX^M5O!MQH?C+0EU> M^E>"_:0I=J)MH,@`R0/0@@^V<=J[[4KZ#3=,N;ZZ<)#;Q-(Y/3`&:\1^'OA# M4M>T"?48)#;PRW;[%S@$87D?CD?A0!7^*'@)M(O9]8?69KQKJ0N5GC&X>VX' M^@K"\!^!H_&.H>3-?M;1KRVR+<6'L2>/R-%%`'6_%#P?:07FD6-A)]FMK2R\ MM$V;B?G)))R.237?_#W3_LWPVMK(R[_DF7?MQU=NWXT44`>2>#?#;V'B^PDC MU!U9I#$'2/:R[P5W`DGD9ST[5E^._!__``BNK/%_:+WI=BQ=X]K'/J"%@3:K'@/[%L]/;%>X:GI5EJ^F3:;?6ZS6LR[6C/ M3';'H1VHHH`\Z6WU'X7W"V>GZG]NTJ=BR6EU%\T.3_"X/],>U=)K'AK2_B+X M(YQP>X..AHHH`\N_X4XO]N?V=_;IV[L;_LG./^^Z]1T3 MPMI7P[\/W,FFPF>?:#--*?GEYZ9[#GH***`.>FM=2^)MRUC?ZI]ATJ%@SVEK F%\TV#_$Y;^F/:O1=.T^UTK3K?3[*(16]O&(XT'8#^9]Z**`/_]D_ ` end -----END PRIVACY-ENHANCED MESSAGE-----